Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gloria Pellizzari"'
Autor:
Carmen Criscitiello, Giuseppe Curigliano, Stefania Morganti, Gloria Pellizzari, Paolo Tarantino, Carmen Belli, Edoardo Crimini, Matteo Repetto, Angela Esposito, Marzia Locatelli, Ida Minchella, Eleonora Nicolo’, Luca Boscolo Bielo, Grazia Castellano, Pier Paolo Maria Berton Giachetti, Gabriele Antonarelli, Liliana Ascione, Carmine Valenza, Beatrice Taurelli Salimbeni
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d2f3c1f2945b4dd3bc96211b63e82c6a
Publikováno v:
Cancers. 15:1130
The treatment of HER2-positive metastatic breast cancer (mBC) with Trastuzumab emtansine (T-DM1) and Trastuzumab deruxtecan (T-DXd), two antibody-drug conjugates (ADCs) targeting HER2, is burdened by progression of disease related to the acquisition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de6441ab93f43ee21acd33a8fcafa970
https://doi.org/10.3390/cancers15041130
https://doi.org/10.3390/cancers15041130
Autor:
Maurizio Sanguinetti, Alessia Savoldi, Francois Franceschi, Evelina Tacconelli, Thomas P. Lodise, Gloria Pellizzari, Dario Menghin, Sally Ellis, Elda Righi, Kamilia Abdelraouf, Elena Carrara, Laura J. V. Piddock, Margherita Chiamenti, Luigia Scudeller, Chiara Rebuffi
Publikováno v:
BMJ Open Science. 44
Objective There is poor evidence to determine the superiority of combination regimens versus monotherapy against infections due to carbapenem-resistant (CR) Gram-negative bacteria. In vivo models can simulate the pathophysiology of infections in huma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c2a44b62da88a01d99afbcaacabe174
https://doi.org/10.1136/bmjos-2019-100055
https://doi.org/10.1136/bmjos-2019-100055